RE:Where is PaulCEO's job is to focus on the business not wasting time placating investors who panic at the first sign of apparent challenges. Nothing changed today -- everyone knows dozens of teams are working on a vaccine and that mitigation efforts will continue well into 2022. Market for BioCloud remains huge.